行情

ENDP

ENDP

远藤国际
NASDAQ

实时行情|Nasdaq Last Sale

3.380
+0.160
+4.97%
交易中 15:21 04/08 EDT
开盘
3.310
昨收
3.220
最高
3.460
最低
3.215
成交量
331.54万
成交额
--
52周最高
8.55
52周最低
1.970
市值
7.67亿
市盈率(TTM)
-2.1235
分时
5日
1月
3月
1年
5年

分析师评级

13位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ENDP价格均价为5.78,最高价位9.00,最低价为3.000。

EPS

ENDP 新闻

更多
  • Covid-19 Could Bring Generic Drug Manufacturing Back to the U.S., Analyst Writes
  • Barrons.com · 1天前
  • Morgan Stanley Maintains Underweight on Endo International, Lowers Price Target to $3
  • Benzinga · 6天前
  • FDA Asks for Recalls of Sanofi's Zantac and All Generic Versions
  • MotleyFool.com · 04/01 18:07
  • Why These 7 Pharma Stocks Are Outplaying 90% Of The Stock Market
  • Investor's Business Daily · 03/31 12:00

所属板块

制药
+3.17%
制药与医学研究
+3.16%

热门股票

代码
价格
涨跌幅

ENDP 简况

Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, Fortesta Gel, Testim, TESTOPEL, Aveed, Supprelin LA and XIAFLEX. Its non-branded U.S. Generic Pharmaceuticals portfolio consists of products, such as tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics and patches. The Company's generics portfolio has a range of dosage forms and delivery systems. The International Pharmaceuticals segment includes various specialty pharmaceutical products for the Canadian, Latin American and world markets.
展开

微牛提供Endo International PLC(NASDAQ-ENDP)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ENDP股票新闻,以帮助您做出投资决策。